Northwest Biotherapeutics (NWBO) Debt Ratio (2016 - 2025)
Historic Debt Ratio for Northwest Biotherapeutics (NWBO) over the last 17 years, with Q3 2025 value amounting to 0.55.
- Northwest Biotherapeutics' Debt Ratio fell 4598.55% to 0.55 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.55, marking a year-over-year decrease of 4598.55%. This contributed to the annual value of 0.82 for FY2024, which is 2234.32% down from last year.
- According to the latest figures from Q3 2025, Northwest Biotherapeutics' Debt Ratio is 0.55, which was down 4598.55% from 0.62 recorded in Q2 2025.
- In the past 5 years, Northwest Biotherapeutics' Debt Ratio registered a high of 12.0 during Q2 2021, and its lowest value of 0.55 during Q3 2025.
- In the last 5 years, Northwest Biotherapeutics' Debt Ratio had a median value of 1.02 in 2024 and averaged 3.02.
- In the last 5 years, Northwest Biotherapeutics' Debt Ratio soared by 73790.51% in 2021 and then plummeted by 8011.64% in 2023.
- Quarter analysis of 5 years shows Northwest Biotherapeutics' Debt Ratio stood at 3.29 in 2021, then decreased by 15.9% to 2.76 in 2022, then tumbled by 61.69% to 1.06 in 2023, then dropped by 22.34% to 0.82 in 2024, then crashed by 33.03% to 0.55 in 2025.
- Its Debt Ratio stands at 0.55 for Q3 2025, versus 0.62 for Q2 2025 and 0.6 for Q1 2025.